Affiliations 

  • 1 Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Deakin University, Burwood, Victoria, Australia
  • 2 Ministry of Women, Early Childhood and Community Wellbeing Development (KPWK), Sarawak, Malaysia
  • 3 Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital and Monash University, Melbourne, Australia
  • 4 Neurosciences Institute, Epworth Richmond, Richmond Victoria, Australia
  • 5 Prevention Division, Cancer Council Victoria
  • 6 Quit, Cancer Council Victoria
  • 7 Research & Policy Manager, BreastScreen Victoria, Australia
  • 8 Thoracic Oncology Group Australasia
  • 9 Health Services & Systems Research, Duke-NUS Medical School, Singapore
  • 10 Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Deakin University, Geelong, Victoria, Australia
JAMA Netw Open, 2025 Mar 03;8(3):e250295.
PMID: 40053349 DOI: 10.1001/jamanetworkopen.2025.0295

Abstract

IMPORTANCE: Surgical cancer treatments may be delayed for patients who smoke over concerns for increased risk of complications. Quantifying risks for people who had recently smoked can inform any trade-offs of delaying surgery.

OBJECTIVE: To investigate the association between smoking status or smoking cessation time and complications after cancer surgery.

DATA SOURCES: Embase, CINAHL, Medline COMPLETE, and Cochrane Library were systematically searched for studies published from January 1, 2000, to August 10, 2023.

STUDY SELECTION: Observational and interventional studies comparing the incidence of complications in patients undergoing cancer surgery who do and do not smoke.

DATA EXTRACTION AND SYNTHESIS: Two reviewers screened results and extracted data according to the Meta-Analyses of Observational Studies in Epidemiology (MOOSE) reporting guidelines. Data were pooled with a random-effects model and adjusted analysis was performed.

MAIN OUTCOMES AND MEASURES: The odds ratio (OR) of postoperative complications (of any type) for people who smoke currently vs in the past (4-week preoperative cutoff), currently smoked vs never smoked, and smoked within shorter (2-week cutoff) and longer (1-year cutoff) time frames.

RESULTS: The meta-analyses across 24 studies with a pooled sample of 39 499 participants indicated that smoking within 4 weeks preoperatively was associated with higher odds of postoperative complications compared with ceasing smoking for at least 4 weeks (OR, 1.31 [95% CI, 1.10-1.55]; n = 14 547 [17 studies]) and having never smoked (OR, 2.83 [95% CI, 2.06-3.88]; n = 9726 [14 studies]). Within the shorter term, there was no statistically significant difference in postoperative complications between people who had smoked within 2 weeks preoperatively and those who had stopped between 2 weeks and 3 months in postoperative complications (OR, 1.19 [95% CI, 0.89-1.59]; n = 5341 [10 studies]), although the odds of complications among people who smoked within a year of surgery were higher compared with those who had quit smoking for at least 1 year (OR, 1.13 [95% CI, 1.00-1.29]; N = 31 238 [13 studies]). The results from adjusted analyses were consistent with the key findings.

CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis of smoking cessation and complications after cancer surgery, people with cancer who had stopped smoking for at least 4 weeks before surgery had fewer postoperative complications than those smoking closer to surgery. High quality, intervention-based evidence is needed to identify the optimal cessation period and inform clinicians on the trade-offs of delaying cancer surgery.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications